J Korean Breast Cancer Soc.  1999 Dec;2(2):240-250. 10.4048/jkbcs.1999.2.2.240.

A Retrospective Study with Immunohistochemical Analysis of Axillary Nodal Micrometastasis in Breast Cancer

Affiliations
  • 1Department of Surgery, Kyung-Hee Hospotal, Seoul, Korea.
  • 2Department of Pathology, Kyung-Hee Hospotal, Seoul, Korea.

Abstract

PURPOSE: It is well established that the presence of axillary nodal metastases is the most important prognostic factor in primary operable breast cancer. However, it has also been shown that 15-30% of patients without lymph node metastases as assessed by light microscopy have recurrence within 10 years. In this study, our aim was first to investigate the diagnostic value of immunohistochemical staining in detecting micrometastases and secondly to correlate their presence with prognosis (recurrence and survival)
MATERIALS AND METHODS
We retrospectively analyzed 492 axillary nodes from 49 consecutive node-negative invasive breast cancers treated at Kyung-Hee University Hospital from 1991 to 1995 with average follow-up of 60.2 (21-100) months. An additional section of original paraffin blocks was cut and stained by immunohistochemical chemical technique using monoclonal antibodies (AE 1/3 and No.7) to cytokeratin.
RESULTS
Micrometastases with individual cell and cell clusters were readily detected by this technique in 27% of the cases. These were no predictors of micrometastses among the clinicopathological data of patient. The presence of micometastases wes not associated with disease-free and overall survival but loco-regional recurrence rate.
CONCLUSIONS
A combination of immunohistochemistry and serial sectioning of axillary lymph node would help evaluate the significance of occult axillary metastases. Patients with node-negative disease may relapse after many years and prolonged follow-up is required to establish the role of mirometastases. Such an approach, together with a search for bone marrow micrometastases and epidemiologic, clinical, pathologic and/or biochemical prognostic factors, may serve to identify high risk patients in the presumed node-negative group. It would provide a rational basis for the selective use of adjuvant therapy.

Keyword

Breast Cancer; Micrometastasis; Immunohistochemistry; Prognostic factors

MeSH Terms

Antibodies, Monoclonal
Bone Marrow
Breast Neoplasms*
Breast*
Follow-Up Studies
Humans
Immunohistochemistry
Keratins
Lymph Nodes
Microscopy
Neoplasm Metastasis
Neoplasm Micrometastasis*
Paraffin
Prognosis
Recurrence
Retrospective Studies*
Antibodies, Monoclonal
Keratins
Paraffin
Full Text Links
  • JKBCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr